PWPS
CRBP icon

Pinnacle Wealth Planning Services’s Corbus Pharmaceuticals CRBP Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.9K Hold
949
– – ﹤0.01% 2114
2026
Q1 		$8.91K Hold
949
– – ﹤0.01% 2050
2025
Q4 		$7.72K Buy
+949
New +$11.7K ﹤0.01% 2117

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Pinnacle Wealth Planning Services's CRBP Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 949 shares worth $8.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Pinnacle Wealth Planning Services first reported a position in CRBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.91K in Q1 2026. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Pinnacle Wealth Planning Services held 949 shares of Corbus Pharmaceuticals worth $8.9K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #2114 holding.
  • Pinnacle Wealth Planning Services first reported a position in Corbus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's Corbus Pharmaceuticals position peaked at $8.91K in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.